General Oncology
MA - BrooklineBiotechnology
Focus: General Oncology is a Boston-area biotechnology company founded in 1990 specializing in cancer therapies across multiple oncology indications. The company operates as a mid-cap biotech with a diversified pipeline spanning early to late-stage development programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About General Oncology
AI assessmentNot HiringNo open roles listed right now. Follow General Oncology to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Stents
Deep Vein ThrombosisClinical Trials (1)
NCT03250247Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
N/AHelp build intelligence for General Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.